GlassScriptPhysician profile
Raquel Welch
NPI 1912431248
$5,024.49
in general payments reported to CMS, 2019-2025
43 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,061 · 2022: $1,908 · 2023: $55.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $55.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $55.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,244.53 | 2021-2023 | |
| Nestle Healthcare Nutrition INC. | $435.29 | 2021-2022 | |
| Novo Nordisk INC | $344.13 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $215.66 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $210.60 | 2021-2022 | |
| Lilly USA, LLC | $199.45 | 2021-2022 | |
| Amgen INC. | $192.89 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $149.72 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $137.23 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $127.66 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $118.75 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $115.10 | 2021-2022 | |
| Pfizer INC. | $109.74 | 2021 | |
| Janssen Pharmaceuticals, INC | $96.74 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $90.85 | 2021-2022 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raquel Welch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.